The Rise of CDMO Services in Biotech and Pharma

In recent years, the pharmaceutical and biotechnology sectors have increasingly turned to Contract Development and Manufacturing Organizations (CDMOs) to streamline their operations. This trend is driven by the need for specialized expertise in drug development and manufacturing, allowing companies to focus on innovation and market expansion. Avid Bioservices, Inc., a prominent player in the biotechnology industry, exemplifies this shift. As a leader in healthcare, Avid Bioservices has embraced CDMO services to enhance its capabilities in polymer-based and lipid-based drug delivery systems. This strategic move not only optimizes their production processes but also positions them at the forefront of cutting-edge drug delivery technologies. With the healthcare sector's growing reliance on CDMOs, companies like Avid Bioservices are setting the standard for efficiency and innovation in the industry.